−1,625 KRW
−118.27 B KRW
87.36 B KRW
76.19 M
About APROGEN BIOLOGICS
Sector
Headquarters
Seoul
Founded
1960
Website
ISIN
KR7003060001
FIGI
BBG000BDT480
Aprogen Biologics, Inc. engages in the manufacture and sale of pharmaceutical products. It operates through the Pharmaceutical Business and Bio Business divisions. The Pharmaceutical Business division provides synthetic pharmaceuticals such as circulatory system drugs, central nervous system drugs, digestive system drugs, and antibiotics. The Bio Business division manufactures biopharmaceuticals. The company was founded on December 3, 1960 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 003060 is 671 KRW — it has decreased by −4.55% in the past 24 hours. Watch APROGEN BIOLOGICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange APROGEN BIOLOGICS stocks are traded under the ticker 003060.
003060 stock has fallen by −8.21% compared to the previous week, the month change is a −8.21% fall, over the last year APROGEN BIOLOGICS has showed a −69.13% decrease.
003060 reached its all-time high on Jul 13, 2004 with the price of 673,515 KRW, and its all-time low was 611 KRW and was reached on Dec 9, 2024. View more price dynamics on 003060 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
003060 stock is 6.60% volatile and has beta coefficient of 1.79. Track APROGEN BIOLOGICS stock price on the chart and check out the list of the most volatile stocks — is APROGEN BIOLOGICS there?
Today APROGEN BIOLOGICS has the market capitalization of 132.57 B, it has increased by 1.24% over the last week.
Yes, you can track APROGEN BIOLOGICS financials in yearly and quarterly reports right on TradingView.
003060 net income for the last quarter is −15.49 B KRW, while the quarter before that showed −23.47 B KRW of net income which accounts for 34.01% change. Track more APROGEN BIOLOGICS financial stats to get the full picture.
No, 003060 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 425.00 employees. See our rating of the largest employees — is APROGEN BIOLOGICS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APROGEN BIOLOGICS EBITDA is −57.70 B KRW, and current EBITDA margin is −56.42%. See more stats in APROGEN BIOLOGICS financial statements.
Like other stocks, 003060 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APROGEN BIOLOGICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APROGEN BIOLOGICS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APROGEN BIOLOGICS stock shows the sell signal. See more of APROGEN BIOLOGICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.